Pharmaceutical formulation

Results: 107



#Item
81Clinical Trial: Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Clinical Trial: Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Add to Reading List

Source URL: www.headlice.org

Language: English - Date: 2006-02-16 15:16:53
82Guidance for Industry  Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products — Chemistry,

Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products — Chemistry,

Add to Reading List

Source URL: www.fda.gov

Language: English
83EPA Form[removed]: Confidential Statement of Formula

EPA Form[removed]: Confidential Statement of Formula

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2012-03-22 16:20:03
84

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
85CHEMICAL PHARMACEUTICAL AND BIOLOGICAL DATA Introduction The product to be used is Wonderdrug 5mg Tablets which are blinded for use in the trial by encapsulation using a Swedish Orange capsule (body and cap) and back-fil

CHEMICAL PHARMACEUTICAL AND BIOLOGICAL DATA Introduction The product to be used is Wonderdrug 5mg Tablets which are blinded for use in the trial by encapsulation using a Swedish Orange capsule (body and cap) and back-fil

Add to Reading List

Source URL: www.mhra.gov.uk

Language: English - Date: 2010-04-07 12:39:26
86Example QbD MR Tablet Module 3 Quality 3.2.P.2 Pharmaceutical Development  Quality by Design for ANDAs: An Example for Modified Release Dosage Forms Introduction to the Example

Example QbD MR Tablet Module 3 Quality 3.2.P.2 Pharmaceutical Development Quality by Design for ANDAs: An Example for Modified Release Dosage Forms Introduction to the Example

Add to Reading List

Source URL: www.fda.gov

Language: English
87Draft Issued for Comment Only. Do Not Use to Submit a Process Filing to FDA DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food Process Filing for Water Activity/Formulation Control Method (Form FDA

Draft Issued for Comment Only. Do Not Use to Submit a Process Filing to FDA DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food Process Filing for Water Activity/Formulation Control Method (Form FDA

Add to Reading List

Source URL: www.fda.gov

Language: English
88AndroGel® (testosterone gel) 1.62% CIII Drug Class and Formulation: Testosterone Drug Products

AndroGel® (testosterone gel) 1.62% CIII Drug Class and Formulation: Testosterone Drug Products

Add to Reading List

Source URL: www.fda.gov

Language: English
89Quality by Design for ANDAs: An Example for Immediate-Release Dosage Forms

Quality by Design for ANDAs: An Example for Immediate-Release Dosage Forms

Add to Reading List

Source URL: www.fda.gov

Language: English
90CO  MA permeability assessment, 36 preclinical studies, 309

CO MA permeability assessment, 36 preclinical studies, 309

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2013-08-23 07:13:50